Colgate-Palmolive sales miss on strong dollar, weak LatAm demand

Go back to Colgate-Palmolive sales miss on strong dollar, weak LatAm demand

UBS Remains Neutral Following Colgate-Palmolive's (CL) 4Q Earnings Report

February 1, 2016 8:43 AM EST

UBS maintained a Neutral rating on Colgate-Palmolive Company (NYSE: CL), and cut the price target to $67.00 (from $69.00), following the company's 4Q earnings report. CL delivered adjusted Q4 EPS of $0.73, $0.01 ahead of consensus. On the positive, CL's 2016 outlook implies a stronger underlying year ahead as... More